Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bone graft & orthobiologics · Utah | Bone graft & orthobiologics · California | |
|---|---|---|
| Surgeons, 2024 | 7 | 57 |
| Medicare fee-for-service cases | 330 | 2,787 |
| Growth since 2019 (Medicare FFS) | −1.7%/yr | −2.3%/yr |
| Forecast cases (Medicare FFS) | 420 in 2030 | 3,030 in 2030 |
| Forecast growth | +4.1%/yr to 2030 | +1.4%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.5 | 0.8 |
| Medicare Advantage share | 57% | 56% |
| Out of hospital | 5% (+4 pts since 2019) | 2% (+2 pts since 2019) |
| Cases per surgeon | 47 | 49 |
| Top 10 surgeons' share | 100% | 44% |
| Surgeons growing | 3 | 6 |
| New since the base year | 2 | 6 |
| Likely to stop billing it | 2 by 2026 | 14 by 2026 |
| Forecast miss, 1 year (procedure) | 12% | 12% |
| Company payments per surgeon | $8,572 | $10K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.